Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

471.48 -6.44 (-1.35%)

Streaming Delayed Price Updated: 10:59 AM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Vertex Pharmaceuticals

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

63 64 Next >

This Market-Beating Growth Stock Is Set to Outperform Yet Again in 2024 ↗

October 26, 2023

This rare disease company is on a roll.

Via The Motley Fool

2 Best Healthcare Stocks to Buy Right Now ↗

October 26, 2023

The healthcare industry is an explosive space full of promising, profitable companies.

Via The Motley Fool

Vertex Pharmaceuticals: Buy at the High? ↗

October 26, 2023

Vertex shares have been flying high in recent times.

Via The Motley Fool

3 Healthcare Stocks to Buy and Hold for the Next 10 Years ↗

October 26, 2023

Great healthcare businesses are out there and their stocks are ripe for the picking.

Via The Motley Fool

2 No-Brainer Growth Stocks to Buy Right Now ↗

October 26, 2023

These businesses are thriving and raking in profits.

Via The Motley Fool

2 Fantastic Growth Stocks to Buy Hand Over Fist ↗

October 26, 2023

These stocks make great bargains today.

Via The Motley Fool

A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings ↗

October 20, 2023

Via Benzinga

The Latest Analyst Ratings for Vertex Pharmaceuticals ↗

October 16, 2023

Via Benzinga

Is Vertex Pharmaceuticals Stock a Buy Now? ↗

October 15, 2023

Jim Cramer recently hyped up one of the company's promising drugs.

Via The Motley Fool

3 Red-Hot Growth Stocks That Are Still Cheap Buys ↗

October 25, 2023

It's not too late to invest in these great businesses.

Via The Motley Fool

Apellis Pharmaceuticals Stock Shows Rising Relative Strength ↗

October 24, 2023

A Relative Strength Rating upgrade for Apellis Pharmaceuticals shows improving technical performance. Will it continue?

Via Investor's Business Daily

The Best Stocks to Invest $5,000 In Right Now ↗

October 24, 2023

Today, the following three healthcare players look like fantastic bargains.

Via The Motley Fool

3 Unstoppable Stocks to Buy Sooner Rather Than Later ↗

October 22, 2023

Now is the time to invest in these great stocks.

Via The Motley Fool

3 Monster Stocks to Buy Without Any Hesitation ↗

October 20, 2023

These big stocks could become a lot bigger.

Via The Motley Fool

4 Ways to Grow $100,000 Into $1 Million for Retirement ↗

October 19, 2023

Investing for big-time growth doesn't have to be risky.

Via The Motley Fool

If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today ↗

October 13, 2023

Via Benzinga

2 Top Biotech Stocks to Buy Right Now ↗

October 12, 2023

Both companies are known innovators.

Via The Motley Fool

Vertex Pharmaceuticals, Gilead Sciences And 2 Other Stocks Insiders Are Selling ↗

October 19, 2023

The Nasdaq 100 closed lower by over 200 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

3 Gene Editing Stocks to Generate Super-Charged Gains ↗

October 18, 2023

As things progress, such techniques may be able to knock out every disease known, creating massive opportunity for gene-editing stocks.

Via InvestorPlace

Intellia Stumbles As It Aims For A First-Ever In CRISPR Gene Editing ↗

October 18, 2023

The company can begin a pivotal study of its treatment for cardiomyopathy.

Via Investor's Business Daily

The Stock Market Is Resilient But How Long Will It Last? Your Mid-October Update ↗

October 17, 2023

We're continuing to see resilience in the US Stock Market in the headwinds of otherwise bearish or bad news, but is this the beginning of a larger rally or may the resiliency come to an end soon?

Via Talk Markets

Mixed Signals For CRISPR Therapeutics, Analyst Weighs Barriers, Potential Sales For Sickle Cell Therapy ↗

October 17, 2023

Cantor Fitzgerald has downgraded CRISPR Therapeutics AG (NASDAQ: CRSP) to Neutral from Ov

Via Benzinga

Healthcare Portfolio Focus Stocks ↗

October 16, 2023

The macro news has been a steady headwind with rising rates offering 5% risk-free treasury yields.

Via Talk Markets

Revolution Medicines Stock Joins Elite Club With RS Ratings Over 90 ↗

October 16, 2023

Revolution Medicines shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Via Investor's Business Daily

2 Healthcare Stocks Near 52-Week Highs Still Worth Buying ↗

October 16, 2023

These two large-cap biopharma companies could have more room to run.

Via The Motley Fool

This Cathie Wood Stock Is Set to Soar 100%, Says Wall Street ↗

October 16, 2023

This Wood favorite is heading for a big moment.

Via The Motley Fool

2 Growth Stocks That Could Double Your Money, According to Wall Street ↗

October 15, 2023

Find out why investment bank analysts are pounding the table on these stocks.

Via The Motley Fool

3 Top Healthcare Stocks to Buy for October ↗

October 12, 2023

These stocks have oodles of room left to run.

Via The Motley Fool

Cathie Wood Is Buying CRISPR Therapeutics Ahead of This Big Event. Should You? ↗

October 10, 2023

Wood has outperformed the market so far this year.

Via The Motley Fool

Jim Cramer's Take on Vertex: Tackling Opioid Addiction with New Drug in Pipeline ↗

October 09, 2023

CNBC's Jim Cramer has drawn investors' attention to Vertex Pharmaceuticals (NASDAQ: VRTX), a biotechnology company currently in the late stages of developing a non-opioid drug to treat acute pain.

Via Benzinga

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

63 64 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.